sought
estim
ascertain
ratio
infect
wuhan
china
use
modifi
bayesian
seir
model
publicli
report
case
data
estim
ci
impli
outbreak
wuhan
abat
deplet
suscept
rather
public
health
action
alon
suggest
hightransmissibilitylowsever
profil
current
pandem
rais
doubt
whether
suppress
rather
mitig
feasibl
goal
coronaviru
diseas
outbreak
origin
end
citi
wuhan
china
current
sweep
globe
confirm
case
death
outbreak
alreadi
turn
latest
global
pandem
one
key
unknown
determin
public
health
impact
infect
fatal
rate
ifr
ie
number
death
proport
person
infect
novel
coronaviru
caus
pathogen
ifr
expect
much
lower
case
fatal
rate
cfr
proport
among
confirm
case
mani
infect
mild
symptom
ascertain
low
ascertain
rate
previous
suggest
base
epidem
model
export
case
wuhan
itali
iran
lockdown
came
forc
januari
wuhan
approxim
close
popul
outbreak
appear
run
cours
case
steadi
declin
sinc
midfebruari
sought
estim
ascertain
rate
appli
epidem
model
publicli
report
confirm
case
wuhan
secondari
object
estim
epidem
paramet
includ
basic
reproduct
number
download
recent
confirm
case
data
wuhan
use
r
packag
period
januari
march
februari
spike
retroact
report
confirm
case
due
chang
case
definit
address
linearli
interpol
new
confirm
case
date
distribut
remaind
previou
date
proport
number
case
alreadi
report
median
incub
period
estim
approxim
day
rang
day
accord
whochina
joint
mission
report
median
time
symptom
onset
laboratori
confirm
wuhan
decreas
day
rang
earli
januari
day
earli
februari
reflect
model
time
case
report
symptom
onset
weibul
distribut
shapescal
paramet
januari
decreas
linearli
februari
similarli
model
time
case
report
case
exposur
infect
weibul
distribut
shapescal
decreas
linearli
figur
distribut
use
reconstruct
estim
epidem
curv
infect
date
symptom
onset
februari
discard
last
two
week
avail
data
subsequ
fit
discretetim
seir
susceptibleexposedinfectedremov
model
modifi
underascertain
fit
bayesian
framework
model
assum
case
observ
fraction
popul
ie
ascertain
rate
stabl
time
assum
case
isol
upon
confirm
thu
remov
infect
pool
time
transit
probabl
time
se
ei
ir
respect
total
number
infect
time
n
popul
wuhan
million
peopl
contact
rate
remov
rate
incub
rate
invers
incub
period
model
equal
basic
reproduct
number
equal
serial
interv
use
noninform
uniform
prior
uniform
ascertain
rate
four
sensit
analys
perform
model
variabl
contact
rate
three
roughli
equal
period
ie
lockdown
februari
februari
variabl
contact
rate
assum
ascertain
rate
assum
drop
contact
rate
lockdown
recent
suggest
simplifi
sir
model
rather
seir
analys
done
r
jag
use
chain
iter
anoth
burnin
model
estim
present
posterior
median
credibl
interv
cri
full
analysi
code
avail
github
http
githubcomthlytrasncovasc
total
confirm
case
report
wuhan
march
report
februari
figur
illustr
confirm
case
estim
epidem
curv
symptom
onset
infect
date
model
result
main
sensit
analys
detail
tabl
ascertain
rate
estim
cri
mean
everi
confirm
case
wuhan
approxim
infect
detect
estim
cri
incub
period
serial
interv
day
respect
latter
remain
ident
sensit
analys
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
assum
variabl
contact
rate
studi
period
estim
would
high
wuhan
lockdown
fall
februari
ascertain
rate
nearli
ident
rate
obtain
simplifi
sir
model
slightli
higher
rate
assum
drop
contact
rate
lockdown
hand
one
assum
fix
ascertain
rate
variabl
contact
rate
would
need
low
right
lockdown
yet
lower
februari
order
fit
data
tabl
sensit
analysi
project
cours
epidem
wuhan
main
analysi
model
shown
figur
estim
half
popul
alreadi
infect
januari
februari
suscept
remain
cri
mean
popul
infect
assum
drop
contact
rate
lockdown
sensit
analysi
percentag
drop
cri
suggest
outbreak
wuhan
control
via
nonpharmaceut
measur
bold
public
health
action
chang
cours
rapidli
escal
epidem
model
suggest
anoth
plausibl
scenario
larg
major
popul
infect
consequ
deplet
suscept
small
percentag
infect
ascertain
otherwis
ascertain
assum
higher
taken
account
larg
reduct
transmiss
need
account
observ
data
infect
prevent
immedi
lockdown
februari
emphas
way
result
diminish
valu
nonpharmaceut
public
health
intervent
mitig
outbreak
underestim
immens
effort
chines
peopl
bold
largescal
action
undoubtedli
allevi
alreadi
difficult
situat
like
succeed
flatten
curv
pandem
maximum
possibl
extent
account
case
ascertain
crucial
accur
assess
true
natur
pandem
ascertain
rate
low
wuhan
suggest
ifr
viru
order
magnitud
lower
cfr
although
underascertain
death
taken
account
well
togeth
estim
would
make
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
archetyp
hightransmiss
lowsever
pandem
whose
high
impact
driven
sheer
number
infect
rather
virul
pathogen
result
impli
larg
amount
transmiss
asymptomat
minim
symptomat
person
rais
doubt
feasibl
suppress
much
less
contain
pandem
current
world
health
organ
still
advoc
contain
strategi
laboratori
test
everi
suspect
case
isol
confirm
case
includ
mild
case
health
facil
trace
contact
laboratori
test
inde
prioriti
surveil
purpos
also
sever
ill
patient
healthcar
worker
select
group
given
find
howev
exhaust
test
contact
trace
probabl
optim
point
countri
ongo
epidem
risk
detract
emin
achiev
end
goal
mitig
flatten
curv
much
possibl
reduc
stress
healthcar
facil
protect
vulner
like
occur
lockeddown
area
china
right
viru
slow
stealthi
progress
rather
freez
given
sever
pandem
threat
effort
spare
public
health
intervent
discount
priori
time
crucial
set
realist
prioriti
realist
expect
well
alloc
resourc
optim
advoc
estim
ascertain
rate
lower
end
previous
publish
estim
wuhan
regardless
precis
rate
though
main
conclus
feasibl
containmentsuppress
lack
thereof
still
hold
also
evidenc
rapid
worldwid
spread
result
also
highlight
urgent
need
seropreval
survey
differ
popul
formal
elucid
true
preval
infect
guid
manag
new
global
pandem
strive
time
data
remain
essenti
optim
public
health
decis
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
